MA26346A1 - Compositions de preparation contenant des composes actifs au plan physiologique et instables aux acides et leur procede de production. - Google Patents

Compositions de preparation contenant des composes actifs au plan physiologique et instables aux acides et leur procede de production.

Info

Publication number
MA26346A1
MA26346A1 MA27683A MA27683A MA26346A1 MA 26346 A1 MA26346 A1 MA 26346A1 MA 27683 A MA27683 A MA 27683A MA 27683 A MA27683 A MA 27683A MA 26346 A1 MA26346 A1 MA 26346A1
Authority
MA
Morocco
Prior art keywords
producing
acid
same
compositions containing
physiologically active
Prior art date
Application number
MA27683A
Other languages
English (en)
Inventor
Shigeru Aoki
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of MA26346A1 publication Critical patent/MA26346A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA27683A 2001-11-21 2004-05-18 Compositions de preparation contenant des composes actifs au plan physiologique et instables aux acides et leur procede de production. MA26346A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001356018 2001-11-21

Publications (1)

Publication Number Publication Date
MA26346A1 true MA26346A1 (fr) 2004-10-01

Family

ID=19167613

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27683A MA26346A1 (fr) 2001-11-21 2004-05-18 Compositions de preparation contenant des composes actifs au plan physiologique et instables aux acides et leur procede de production.

Country Status (25)

Country Link
EP (1) EP1454634A4 (fr)
JP (1) JP4540092B2 (fr)
KR (1) KR20050044545A (fr)
CN (2) CN101982199A (fr)
AP (1) AP1919A (fr)
AU (1) AU2002366029B2 (fr)
BR (1) BR0214372A (fr)
CA (1) CA2466726C (fr)
CO (1) CO5580800A2 (fr)
CR (1) CR7351A (fr)
EC (1) ECSP045110A (fr)
HU (1) HUP0402323A3 (fr)
IL (2) IL161983A0 (fr)
IS (1) IS7266A (fr)
MA (1) MA26346A1 (fr)
MX (1) MXPA04004775A (fr)
NO (1) NO20042563L (fr)
NZ (1) NZ532907A (fr)
RO (1) RO122395B1 (fr)
RU (1) RU2311906C2 (fr)
SI (1) SI21447A (fr)
TW (1) TWI302461B (fr)
UA (1) UA76256C2 (fr)
WO (1) WO2003043661A1 (fr)
ZA (1) ZA200403551B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
CN1938026A (zh) * 2004-03-26 2007-03-28 卫材R&D管理有限公司 控释制剂及其制造方法
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
CA2584957C (fr) 2004-10-21 2015-08-25 Eurand Pharmaceuticals Limited Compositions pharmaceutiques a saveur masquee avec substances porogenes gastrosolubles
CA2592605C (fr) 2004-12-27 2010-12-07 Eisai R&D Management Co., Ltd. Methode de stabilisation d'un medicament contre la demence
WO2006123364A2 (fr) * 2005-03-14 2006-11-23 Sun Pharmaceutical Industries Limited Systeme d'administration de medicament par voie orale
WO2006111853A2 (fr) * 2005-04-18 2006-10-26 Aurobindo Pharma Limited Formes posologiques solides stables d'un medicament labile en milieu acide
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
WO2008062320A2 (fr) 2006-10-06 2008-05-29 Eisai R&D Management Co., Ltd Formulations à libération prolongée d'un inhibiteur de la pompe à protons
WO2009069280A1 (fr) * 2007-11-27 2009-06-04 Ohara Pharmaceutical Co., Ltd. Procédé de production d'une substance granulée
CN101822671A (zh) * 2009-03-06 2010-09-08 信谊药厂 雷贝拉唑组合物及其制备方法
WO2011067667A2 (fr) 2009-12-02 2011-06-09 Eurand Pharmaceuticals Limited Microcapsules de fexofénadine et compositions les contenant
NZ605562A (en) * 2010-07-09 2013-11-29 Teijin Pharma Ltd Deuterated benzylbenzene derivatives and methods of use
JP2018184360A (ja) * 2017-04-25 2018-11-22 ニプロ株式会社 経口投与用の腸溶性徐放性製剤
KR102227486B1 (ko) * 2017-06-30 2021-03-12 롯데정밀화학 주식회사 프로톤 펌프 저해제를 포함하는 경구용 고형제제 조성물, 이를 포함하는 경구용 고형제제 및 그 제조방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
JPS5944311A (ja) * 1982-09-07 1984-03-12 Santen Pharmaceut Co Ltd 徐放性顆粒およびその製造法
ATE124864T1 (de) * 1989-03-10 1995-07-15 Yamanouchi Pharma Co Ltd Die wirkstoffabgabe steuerndes überzugsmaterial für lang wirksame formulierungen.
EP0447168A3 (en) * 1990-03-16 1993-01-07 Yamanouchi Pharmaceutical Co. Ltd. Long acting granular pharmaceutical composition
JPH0826977A (ja) * 1994-07-19 1996-01-30 Tanabe Seiyaku Co Ltd 溶出制御型経口製剤
JPH09323926A (ja) * 1996-03-15 1997-12-16 Nikken Chem Co Ltd バルプロ酸ナトリウムの徐放性錠剤
ES2137862B1 (es) * 1997-07-31 2000-09-16 Intexim S A Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
WO1999053918A1 (fr) * 1998-04-20 1999-10-28 Eisai Co., Ltd. Compositions stabilisees contenant des composes du type benzimidazole
DK1736144T3 (en) * 1998-05-18 2015-12-07 Takeda Pharmaceutical Orally disintegrating tablets.
JP2001055322A (ja) * 1999-08-18 2001-02-27 Tanabe Seiyaku Co Ltd パルス放出型製剤
DK1222922T3 (da) * 1999-10-20 2007-12-03 Eisai R&D Man Co Ltd Fremgangsmåde til stabilisering af benzimidazolforbindelser
US6627223B2 (en) * 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems

Also Published As

Publication number Publication date
KR20050044545A (ko) 2005-05-12
TWI302461B (en) 2008-11-01
EP1454634A1 (fr) 2004-09-08
CO5580800A2 (es) 2005-11-30
RU2004118495A (ru) 2005-03-20
NO20042563L (no) 2004-06-18
NZ532907A (en) 2007-05-31
AU2002366029B2 (en) 2008-01-31
CN101982199A (zh) 2011-03-02
WO2003043661A1 (fr) 2003-05-30
BR0214372A (pt) 2004-10-26
CN1589156A (zh) 2005-03-02
AU2002366029A1 (en) 2003-06-10
IS7266A (is) 2004-05-14
CA2466726A1 (fr) 2003-05-30
UA76256C2 (en) 2006-07-17
RU2311906C2 (ru) 2007-12-10
MXPA04004775A (es) 2005-02-17
RO122395B1 (ro) 2009-05-29
AP1919A (en) 2008-11-13
AP2004003045A0 (en) 2004-06-30
JPWO2003043661A1 (ja) 2005-03-10
TW200300353A (en) 2003-06-01
EP1454634A4 (fr) 2007-05-30
JP4540092B2 (ja) 2010-09-08
ECSP045110A (es) 2004-08-27
ZA200403551B (en) 2005-07-07
SI21447A (sl) 2004-10-31
HUP0402323A3 (en) 2008-04-28
CR7351A (es) 2005-05-12
CA2466726C (fr) 2011-02-22
IL161983A0 (en) 2005-11-20
HUP0402323A2 (hu) 2005-02-28
IL161983A (en) 2009-11-18

Similar Documents

Publication Publication Date Title
MA26346A1 (fr) Compositions de preparation contenant des composes actifs au plan physiologique et instables aux acides et leur procede de production.
MA27410A1 (fr) Nouveaux composes pyridopyrimidinone leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2004055006A8 (fr) Nouveaux composes presentant un effet inhibiteur selectif de la gsk3
IL219397A0 (en) Compounds for the treatment of metabolic disorders, methods of preparing same, and pharmaceutical compositions containing same
IL165977A (en) Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same
PL400027A1 (pl) Wieloelementowa farmaceutyczna postac dawkowania i sposób jej wytwarzania
WO2002047668A3 (fr) Nouvelles compositions medicamenteuses a base d'anticholinergiques et de ciclesonide
FR2825925B1 (fr) Procede de preparation d'un principe actif a partir de riz, principe actif obtenu et compositions adaptees
IS8430A (is) Lyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinn
HUP0400155A3 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
AU2002238855A1 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
ATE367152T1 (de) Herstellungsverfahren für niedrig dosierte pharmazeutische zusammensetzung
MXPA02012889A (es) Esteres de acidos 4-alcoxi-ciclohexano-1-amino-carboxilicos y procedimiento para su obtencion.
ATE291908T1 (de) Ibuprofen-wirkstoffzubereitung
FR2848851B1 (fr) Procede d'obtention d'un principe actif presentant des capacites apaisantes, principe actif et compositions obtenues
IL157709A0 (en) Process for the preparation of 1,2-benzisoxazole-3-acetic acid
HUP0600084A2 (en) Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
FR2890312B1 (fr) Procede d'obtention d'un principe actif repulpant, principe actif obtenu et compositions cosmetiques l'incluant
AU2002325614A1 (en) Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances
AU2002223617A1 (en) Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds
HUP0002147A3 (en) Hydroxybenzoic acid derivatives, process for producing them and pharmaceutical compositions having antiplasmid activity comprising the said compounds
IL144063A0 (en) Process for the preparation of 1,1-cyclohexanediacetic acid
AU2003303775A1 (en) Novel physiologically active substance rs-k3574 and process for producing the same
FR2819509B1 (fr) Nouveaux composes cycloheptene, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2855749B1 (fr) Procede d'obtention d'un principe actif dote de proprietes de photoprotection, principe actif obtenu et compositions l'incluant